$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000139681419000014 Filed on May 02, 2019

Income Statement

Concept	2019 Q1	2018 Q4	2018 Q1
Revenue	$91.31M	$95.12M	$74.61M
YoY Change	22.39%	20.28%	7.68%
Cost Of Revenue	$27.30M	$23.98M	$22.89M
YoY Change	19.31%	12.6%	-6.9%
Gross Profit	$64.01M	$71.14M	$51.72M
YoY Change	23.76%	23.11%	15.7%
Gross Profit Margin	70.1%	74.79%	69.33%
Selling, General & Admin	$47.31M	$44.60M	$44.19M
YoY Change	7.05%	13.78%	4.92%
% of Gross Profit	73.9%	62.7%	85.44%
Research & Development	$14.38M	$14.20M	$14.38M
YoY Change	0.04%	42.0%	-13.55%
% of Gross Profit	22.47%	19.96%	27.8%
Depreciation & Amortization	$3.600M	$4.060M	$2.762M
YoY Change	30.34%	10.93%	-11.02%
% of Gross Profit	5.62%	5.71%	5.34%
Operating Expenses	$90.23M	$82.85M	$81.54M
YoY Change	10.66%	17.33%	-2.15%
Operating Profit	$1.079M	-$11.72M	-$6.937M
YoY Change	-115.55%	-8.68%	-50.63%
Interest Expense	$5.814M	-$3.800M	$5.157M
YoY Change	12.74%	0.0%	99.19%
% of Operating Profit	538.83%
Other Income/Expense, Net	-$3.597M	-$200.0K	-$3.708M
YoY Change	-2.99%		-35.91%
Pretax Income	-$2.518M	$8.300M	-$10.65M
YoY Change	-76.35%	80.43%	-46.33%
Income Tax	$253.0K	$0.00	$35.00K
% Of Pretax Income		0.0%
Net Earnings	-$2.771M	$8.285M	-$10.68M
YoY Change	-74.05%	80.3%	-46.24%
Net Earnings / Revenue	-3.03%	8.71%	-14.32%
Basic Earnings Per Share	-$0.07		-$0.26
Diluted Earnings Per Share	-$0.07	$201.9K	-$262.9K
COMMON SHARES
Basic Shares Outstanding	41.24M shares	41.11M shares	40.71M shares
Diluted Shares Outstanding	41.24M shares

Balance Sheet

Concept	2019 Q1	2018 Q4	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$412.4M	$383.5M	$339.8M
YoY Change	21.37%	23.19%	-11.44%
Cash & Equivalents	$215.0M	$132.5M	$41.56M
Short-Term Investments	$197.4M	$250.9M	$298.2M
Other Short-Term Assets	$9.400M	$7.900M	$7.700M
YoY Change	22.08%	17.91%	22.22%
Inventory	$47.03M	$48.57M	$40.04M
Prepaid Expenses
Receivables	$39.77M	$38.00M	$31.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$508.7M	$478.0M	$418.7M
YoY Change	21.48%	22.21%	-6.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$107.1M	$108.7M	$109.2M
YoY Change	-1.99%	1.52%	6.49%
Goodwill	$62.00M	$62.04M	$57.49M
YoY Change	7.84%	12.4%	17.74%
Intangibles		$0.00
YoY Change
Long-Term Investments	$14.10M	$40.00M	$35.80M
YoY Change	-60.61%	-46.09%
Other Assets	$560.0K	$657.0K	$759.0K
YoY Change	-26.22%	-20.36%	26.92%
Total Long-Term Assets	$210.5M	$211.4M	$203.3M
YoY Change	3.53%	-10.91%	33.75%
TOTAL ASSETS
Total Short-Term Assets	$508.7M	$478.0M	$418.7M
Total Long-Term Assets	$210.5M	$211.4M	$203.3M
Total Assets	$719.2M	$689.4M	$622.0M
YoY Change	15.61%	9.7%	3.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.37M	$14.37M	$14.91M
YoY Change	-10.35%	-1.98%	59.11%
Accrued Expenses	$39.70M	$45.87M	$33.02M
YoY Change	20.23%	11.71%	-5.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$300.0K	$300.0K
YoY Change	-100.0%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$58.99M	$60.66M	$48.37M
YoY Change	21.96%	7.91%	5.96%
LONG-TERM LIABILITIES
Long-Term Debt	$294.4M	$290.6M	$279.7M
YoY Change	5.26%	5.21%	5.15%
Other Long-Term Liabilities	$8.993M	$16.87M	$15.46M
YoY Change	-41.84%	2.28%	49.66%
Total Long-Term Liabilities	$8.993M	$16.87M	$15.46M
YoY Change	-41.84%	2.28%	49.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$58.99M	$60.66M	$48.37M
Total Long-Term Liabilities	$8.993M	$16.87M	$15.46M
Total Liabilities	$391.6M	$368.1M	$343.5M
YoY Change	14.01%	5.51%	4.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$391.2M	-$388.2M	-$398.5M
YoY Change	-1.83%	-0.23%	8.75%
Common Stock	$41.00K	$41.00K	$41.00K
YoY Change	0.0%	0.0%	2.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares	0.000 shares
Shareholders Equity	$327.5M	$321.2M	$278.5M
YoY Change
Total Liabilities & Shareholders Equity	$719.2M	$689.4M	$622.0M
YoY Change	15.61%	9.7%	3.68%

Cashflow Statement

Concept	2019 Q1	2018 Q4	2018 Q1
OPERATING ACTIVITIES
Net Income	-$2.771M	$8.285M	-$10.68M
YoY Change	-74.05%	80.3%	-46.24%
Depreciation, Depletion And Amortization	$3.600M	$4.060M	$2.762M
YoY Change	30.34%	10.93%	-11.02%
Cash From Operating Activities	$3.499M	$21.22M	-$2.690M
YoY Change	-230.07%	25.27%	-27000.0%
INVESTING ACTIVITIES
Capital Expenditures	$2.018M	-$2.240M	$5.184M
YoY Change	-61.07%	-55.91%	43.36%
Acquisitions
YoY Change
Other Investing Activities	$80.50M	-$120.9M	-$5.110M
YoY Change	-1675.34%	-978.14%	-96.36%
Cash From Investing Activities	$78.48M	-$123.2M	-$10.29M
YoY Change	-862.69%	-1517.26%	-92.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$530.0K	3.520M	$419.0K
YoY Change	26.49%	54.39%	-99.81%
NET CHANGE
Cash From Operating Activities	$3.499M	21.22M	-2.690M
Cash From Investing Activities	$78.48M	-123.2M	-10.29M
Cash From Financing Activities	$530.0K	3.520M	$419.0K
Net Change In Cash	$82.51M	-98.42M	$419.0K
YoY Change	19592.12%	-452.63%	-99.81%
FREE CASH FLOW
Cash From Operating Activities	$3.499M	$21.22M	-$2.690M
Capital Expenditures	$2.018M	-$2.240M	$5.184M
Free Cash Flow	$1.481M	$23.46M	-$7.874M
YoY Change	-118.81%	6.54%	118.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2019Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-388226000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	182000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-280000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	327519000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41222799	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41288703	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41222799	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41288703	shares
CY2018Q1	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62000000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41296937	shares
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	215036000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2019Q1	us-gaap	Short Term Investments ShortTermInvestments	197406000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	250928000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39766000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38000000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	47028000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	48569000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9437000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7946000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	508673000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	477969000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	25871000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107051000	USD
CY2019Q1	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108670000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	26686000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q1	us-gaap	Goodwill Goodwill	62040000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62040000	USD
CY2019Q1	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2018Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	560000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	657000	USD
CY2019Q1	us-gaap	Assets Assets	719156000	USD
CY2018Q4	us-gaap	Assets Assets	689353000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	13369000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14368000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	39696000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45865000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5583000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2018Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	338000	USD
CY2019Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	343000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	90000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	58991000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	60661000	USD
CY2019Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	294356000	USD
CY2018Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	290592000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29297000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8993000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16874000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	391637000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	368127000	USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	718449000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	709691000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-391153000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	719156000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	689353000	USD
CY2019Q1	us-gaap	Revenues Revenues	91313000	USD
CY2018Q1	us-gaap	Revenues Revenues	74607000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	27303000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	22885000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14384000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14378000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	48518000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44191000	USD
CY2019Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-29000	USD
CY2018Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-90000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	90234000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	81544000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1079000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6937000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2156000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1374000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	5814000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	5157000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	61000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	75000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3597000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3708000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2518000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10645000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	253000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2771000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41240000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40707000	shares
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2771000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	462000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-447000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	462000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-447000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2309000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11127000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-156000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1557000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7434000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	462000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2771000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	327519000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1361000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	419000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8385000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-447000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	278521000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2771000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3600000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2762000	USD
CY2019Q1	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	420000	USD
CY2018Q1	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	391000	USD
CY2019Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3345000	USD
CY2018Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3113000	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7434000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8385000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1766000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-798000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1540000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1368000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1644000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1210000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1442000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	106000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5166000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7623000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-51000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-109000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3499000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2689000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2018000	USD
CY2019Q1	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5184000	USD
CY2019Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	22688000	USD
CY2018Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	130580000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	103187000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	127764000	USD
CY2018Q1	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	2293000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	78481000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-10293000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1101000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	419000	USD
CY2019Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	338000	USD
CY2018Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2019Q1	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	233000	USD
CY2018Q1	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	530000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	419000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	82510000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-12563000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	215036000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41563000	USD
CY2019Q1	us-gaap	Interest Paid InterestPaid	5000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	4102000	USD
CY2019Q1	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	37000	USD
CY2018Q1	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	233000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90906000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74287000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19978000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19193000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11141000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9711000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15909000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19665000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	47028000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	48569000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	172209000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	170228000	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	65158000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61558000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107051000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108670000	USD
CY2019Q1	us-gaap	Depreciation Depreciation	3600000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	2800000	USD
CY2019Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	USD
CY2019Q1	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	63400000	USD
CY2018Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	64600000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P4Y
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1443000	USD
CY2018Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1490000	USD
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	381000	USD
CY2018Q1	us-gaap	Variable Lease Cost VariableLeaseCost	402000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	1824000	USD
CY2018Q1	us-gaap	Lease Cost LeaseCost	1892000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2050000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	34780000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M2D
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0810
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6090000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7700000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5539000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	5671000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	5806000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	14788000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	45594000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	10714000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	34880000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	8140000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7621000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5295000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5417000	USD
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5543000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	14329000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	46345000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	62000000.0	USD
CY2019Q1	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2019Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	300000	USD
CY2019Q1	pcrx	Repaymentof Conversion Premium RepaymentofConversionPremium	200000	USD
CY2019Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2018Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	us-gaap	Share Price SharePrice	38.06
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2017	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7434000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8385000	USD
CY2019Q1	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	4930000	USD
CY2018Q1	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6356000	USD
CY2019Q1	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	191000	USD
CY2018Q1	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	38000	USD
CY2019Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	2107000	USD
CY2018Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	1790000	USD
CY2019Q1	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	206000	USD
CY2018Q1	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	201000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7434000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8385000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	19.38
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2019Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0	shares
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2771000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41240000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40707000	shares
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6388000	shares
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5558000	shares
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1819000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9813000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-4337000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-832000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2518000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10645000	USD
CY2019Q1	pcrx	Income Tax Provision IncomeTaxProvision	300000	USD
CY2018Q1	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2018Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1970000	USD
CY2018Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	282000	USD
CY2018Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	2252000	USD
CY2019Q1	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	0	USD
CY2019Q1	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	11000	USD
CY2019Q1	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	0	USD
CY2019Q1	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	71000	USD
CY2019Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	71000	USD
CY2019Q1	pcrx	Lease Cost Reclassification LeaseCostReclassification	-1970000	USD
CY2019Q1	pcrx	Asset Retirement Obligation Reclassification AssetRetirementObligationReclassification	455000	USD
CY2019Q1	us-gaap	Business Exit Costs1 BusinessExitCosts1	-1515000	USD
CY2019Q1	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	0	USD
CY2019Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	677000	USD
CY2019Q1	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	677000	USD

Files In Submission

Name	View Source	Status
0001396814-19-000014-index-headers.html	Edgar Link	pending
0001396814-19-000014-index.html	Edgar Link	pending
0001396814-19-000014.txt	Edgar Link	pending
0001396814-19-000014-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pacirabiosciences.jpg	Edgar Link	pending
pcrx-20190331.xsd	Edgar Link	pending
pcrx-20190331_cal.xml	Edgar Link	unprocessable
pcrx-20190331_def.xml	Edgar Link	unprocessable
pcrx-20190331_lab.xml	Edgar Link	unprocessable
pcrx-20190331_pre.xml	Edgar Link	unprocessable
pcrx-3312019x10xq.htm	Edgar Link	pending
pcrx-3312019x10xq_htm.xml	Edgar Link	completed
pcrx-3312019xex101.htm	Edgar Link	pending
pcrx-3312019xex311.htm	Edgar Link	pending
pcrx-3312019xex312.htm	Edgar Link	pending
pcrx-3312019xex321.htm	Edgar Link	pending
pcrx-3312019xex41.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
specimencommonstock1.jpg	Edgar Link	pending
specimencommonstock2.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2019 Q1 Form 10-Q Financial Statement

#000139681419000014 Filed on May 02, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2019 Q1 Form 10-Q Financial Statement

#000139681419000014 Filed on May 02, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx